Reframing The Novo Nordisk (CPSE:NOVO B) Narrative As Analysts Reset Expectations And Valuation [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Novo Nordisk's fair value estimate has been revised from DKK 376.59 to DKK 330.95, a shift that pulls the price target about 12% closer to updated earnings assumptions. Analysts describe this reset as a move toward more conservative expectations rather than a reaction to a single company specific shock. As you read on, you will see how this evolving analyst narrative might shape the way you track and interpret Novo Nordisk's valuation story from here. Stay updated as the Fair Value for Novo Nordisk shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Novo Nordisk. What Wall Street Has Been Saying ?? Bullish Takeaways The reset in fair value to DKK 330.95 aligns Novo Nordisk's valuation more closely with updated earnings assumptions. Some investors may view this as a cleaner, less stretched starting point for assessing upside or downside. Analysts frame the move as a shift toward more conservative inputs ra
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Drugmaker Aspen plans Africa weight-loss drug push [Yahoo! Finance]Yahoo! Finance
- CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry [Seeking Alpha]Seeking Alpha
- Novo Nordisk (NVO) Reports 10% Sales Growth as Obesity Care Hits DKK 82B [Yahoo! Finance]Yahoo! Finance
- Study Says Ozempic Knockoffs Could Cost $3 [Yahoo! Finance]Yahoo! Finance
- Zealand's stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics' [CNBC]CNBC
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/2/26 - Form 6-K
- 3/2/26 - Form 6-K
- 2/23/26 - Form 6-K
- NVO's page on the SEC website